Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis | Radiation Oncology | Full Text

Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis | Radiation Oncology | Full Text

Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis

To estimate the efficacy of neoadjuvant chemotherapy (NCT) in stage T3-4N1 nasopharyngeal carcinoma (NPC).

Authors:Lei Wang, Zheng Wu, Dehuan Xie, Shaowen Lv, Liangping Xia and Yong Su

Citation:Radiation Oncology 2020 15:160

Content type:Research

 

Published on: 2 July 2020

• ViewFull Text
 
• ViewPDF